background and objectives: acinetobacter spp. are important causes of nosocomial infections. they possess various antibiotic resistance mechanisms including extended spectrum beta lactamases (esbls). the aim of this study was to determine antibiotic resistance profile of acinetobacter clinical isolates especially among esbl-producing strains and to investigate the antimicrobial effects of oleo-...

Introduction The high prevalence of urinary tract infections (UTIs) and rising resistance to beta-lactam antibiotics, which is a global therapeutic concern, are caused by Escherichia coli (E. coli) extended-spectrum beta-lactamases (ESBLs) producers. It unclear how E. that produces ESBLs spreads throughout Gezira state, Sudan. study aimed evaluate the dissemination class A D genes among recogni...

Background & Aims: Organisms producing TEM-β-lactamase are emerging around the world as a source of resistance to β-lactam antibiotics such as three generation cephalosporins. In this study, we used a polymerase chain reaction (PCR) to identify genes TEM for Extended-spectrum β-lactamase (ESBLs) producing clinical isolates of Klebsiella pneumonia from hospitals of Boro...

conclusions the β-lactamase disk test is appropriately sensitive to detect esbls in mdr isolates of e. coli. background most urinary tract infections (utis) are caused by escherichia coli (e. coli) species. due to infections outbreaks of e. coli strains with multiple mechanisms of resistance to β-lactam antibiotics, the sensitivity of confirmatory tests to detect the extended spectrum β-lactama...

BACKGROUND ESBL occur mostly in Enterobacteriaceae e.g. Escherichia coli. ESBLs are clinically important because they destroy cephalosporin's, work horse hospital antibiotics, given as first line agents to many severely ill patients. Delayed recognition and inappropriate treatment of severe infections caused by ESBL producers with cephalosporin has been associated with increased mortality. ESBL...

Infections due to extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (ESBLEC) in nonhospitalized patients seem to be emerging in different countries. Their incidence, epidemiology, and clinical impact in the community have not been studied. We describe the epidemiology and clinical features of infections caused by ESBLEC in nonhospitalized patients in Spain and the results of a ...